Cell and Gene therapy are the new frontiers in the fight against devastating diseases, including rare diseases and cancers.

Clinical trial results have been promising, and the next generation of Cell and Gene therapies holds tremendous promise for many patients and families.

The development of Cell and Gene Therapies is challenging due to complex study designs, adequately monitoring of adverse reactions, long-term immune response and safety follow-up. BBCR has successfully delivered cost-effective clinical plans and regulatory strategies for Cell and Gene therapy programs in Oncology and Rare diseases.

Reach out today to learn more

Specializing in rare disease, Boston Biotech Clinical Research works with biotech, pharmaceutical, device companies and investors to streamline the clinical trial process. Our experienced team helps each client reach their specific goals by customizing a clinical and regulatory road map of simplified programs and streamlined protocols to meet our clients’ requirements.

"*" indicates required fields

NAME:*

EMAIL:*

PHONE NUMBER:

COMMENTS:*

CAPTCHA

Comments

This field is for validation purposes and should be left unchanged.